Provides a comprehensive overview of Kv7 channel physiology and the development of selective pharmacological modulators for therapeutic applications.
Answers are grounded in this paper and cite their sources.
Supports Kv7 modulator research in cardiac and neurological disease; leaves open clinical translation pending trials.
K(v)7 channels are unique among K(+) channels, since four out of the five channel subtypes have well-documented roles in the development of human diseases. They have distinct physiological functions in the heart and in the nervous system, which can be ascribed to their voltage-gating properties. The K(v)7 channels also lend themselves to pharmacological modulation, and synthetic openers as well as blockers of the channels, regulating neuronal excitability, have existed even before the K(v)7 channels were identified by cloning. In the present review we give an account on the focused efforts to develop selective modulators, openers as well as blockers, of the K(v)7 channel subtypes, which have been undertaken during recent years, along with a discussion of the K(v)7 ion channel physiology and therapeutic indications for modulators of the neuronal K(v)7 channels.
No takes yet. Share an insight, caveat, or question.
Dalby‐Brown et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: